Shevelev AA - Search Results

1

Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle.

Traktuev DO, Tsokolaeva ZI, Shevelev AA, Talitskiy KA, Stepanova VV, Johnstone BH, Rahmat-Zade TM, Kapustin AN, Tkachuk VA, March KL, Parfyonova YV. Traktuev DO, et al. Among authors: shevelev aa. Mol Ther. 2007 Nov;15(11):1939-46. doi: 10.1038/sj.mt.6300262. Epub 2007 Jul 24. Mol Ther. 2007. PMID: 17653104 Free article.

2

Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumorigenicity of glioblastoma in an animal model.

Shevelev A, Burfeind P, Schulze E, Rininsland F, Johnson TR, Trojan J, Chernicky CL, Hélène C, Ilan J, Ilan J. Shevelev A, et al. Cancer Gene Ther. 1997 Mar-Apr;4(2):105-12. Cancer Gene Ther. 1997. PMID: 9080119

3

Developmentally imprinted genes as markers for bladder tumor progression.

Cooper MJ, Fischer M, Komitowski D, Shevelev A, Schulze E, Ariel I, Tykocinski ML, Miron S, Ilan J, de Groot N, Hochberg A. Cooper MJ, et al. J Urol. 1996 Jun;155(6):2120-7. J Urol. 1996. PMID: 8618347

4

IGF-I triple helix gene therapy of rat and human gliomas.

Trojan LA, Kopinski P, Mazurek A, Chyczewski L, Ly A, Jarocki P, Nikliński J, Shevelev A, Trzos R, Pan Y, Gitis DJ, Bierwagen M, Czapiewska JL, Wei MX, Michalkiewicz J, Henin D, Popiela T, Evrard F, Kasprzak H, Anthony D, Trojan J. Trojan LA, et al. Rocz Akad Med Bialymst. 2003;48:18-27. Rocz Akad Med Bialymst. 2003. PMID: 14737936

5

Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation.

Trojan J, Johnson TR, Rudin SD, Blossey BK, Kelley KM, Shevelev A, Abdul-Karim FW, Anthony DD, Tykocinski ML, Ilan J, et al. Trojan J, et al. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6088-92. doi: 10.1073/pnas.91.13.6088. Proc Natl Acad Sci U S A. 1994. PMID: 8016120 Free PMC article.

6

IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.

Trojan LA, Kopinski P, Wei MX, Ly A, Glogowska A, Czarny J, Shevelev A, Przewlocki R, Henin D, Trojan J. Trojan LA, et al. Acta Biochim Pol. 2002;49(4):979-90. Acta Biochim Pol. 2002. PMID: 12545204 Review.

7

IGF-I triple helix strategy in hepatoma treatment.

Upegui-Gonzalez LC, Ly A, Sierzega M, Jarocki P, Trojan L, Duc HT, Pan Y, Shevelev A, Henin D, Anthony D, Nowak W, Popiela T, Trojan J. Upegui-Gonzalez LC, et al. Hepatogastroenterology. 2001 May-Jun;48(39):660-6. Hepatogastroenterology. 2001. PMID: 11462897

8

Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Ly A, Duc HT, Kalamarides M, Trojan LA, Pan Y, Shevelev A, François JC, Noël T, Kane A, Henin D, Anthony DD, Trojan J. Ly A, et al. Mol Pathol. 2001 Aug;54(4):230-9. doi: 10.1136/mp.54.4.230. Mol Pathol. 2001. PMID: 11477137 Free PMC article.

9

The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma.

Elkin M, Shevelev A, Schulze E, Tykocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A. Elkin M, et al. FEBS Lett. 1995 Oct 23;374(1):57-61. doi: 10.1016/0014-5793(95)01074-o. FEBS Lett. 1995. PMID: 7589512 Free article.

10

Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours.

Trojan J, Pan YX, Wei MX, Ly A, Shevelev A, Bierwagen M, Ardourel MY, Trojan LA, Alvarez A, Andres C, Noguera MC, Briceno I, Aristizabal BH, Kasprzak H, Duc HT, Anthony DD. Trojan J, et al. Chemother Res Pract. 2012;2012:721873. doi: 10.1155/2012/721873. Epub 2012 Feb 14. Chemother Res Pract. 2012. PMID: 22400112 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page